Wednesday 02 June 2021 5:29 pm

Expansion of Pfizer manufacturing capacity in Belgium approved by EMA body

Pfizer said that more than 1bn doses of the vaccine have been delivered globally, and it expects to deliver 2.1bn more doses by the end of the year, under contracts signed as of mid-July.

The Committee for Human Medicines, part of the European Medicines Agency (EMA), has recommended the approval of additional manufacturing and filling lines at Pfizer’s manufacturing site in Puurs, Belgium.

According to the EMA, the move would result in a “significant and immediate impact on the supply” of the Covid-19 vaccine developed by BioNTech and Pfizer.

The committee reviewed data submitted by BioNTech, finding that the Puurs facility can consistently produce high-quality vaccines and is capable of increasing production volumes.